-
Virginie Buggia-Prevot, PhD
… Target Portfolio Strategy across therapeutic areas at Valo Health, a technology company leveraging human data and …
-
Philippa Mills, PhD
… She then joined UCL Great Ormond Street Institute of Child Health, London as a Post-Doctoral fellow in the Mass …
-
Myron Flint Beal, MD
… Foundation, ALS Association, and the American Health Assistance Foundation, and is a member of the …
-
John G. Nutt, MD
… of neurology and physiology/pharmacology at Oregon Health and Science University, and director emeritus of the … and the treatment of Parkinson's disease. His work in experimental therapeutics has been seminal in understanding the …
-
Donato A. Di Monte, MD
… Institute in Stockholm, Sweden, and at the School of Public Health at University of California, Berkeley. Parkinson’s … Diseases (DZNE) in Bonn, Germany. Using experimental models of Parkinson-like pathology, which were often … are triggered and modulated by risk factors, such as environmental challenges, gene-environment interactions and aging. …
-
Michael G. Schlossmacher, MD
… focuses on exploring environment-gene interactions in brain health with an emphasis on the olfactory route, parkin’s …